Richard Saitz1,2, Aldina Mesic1, Alicia S Ventura2, Michael R Winter3, Timothy C Heeren4, Meg M Sullivan5, Alexander Y Walley2, Gregory J Patts3, Seville M Meli1, Michael F Holick6, Theresa W Kim2, Kendall J Bryant7, Jeffrey H Samet1,2. 1. Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts. 2. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, Massachusetts. 3. Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts. 4. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts. 5. Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts. 6. Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, School of Medicine and Boston Medical Center, Boston University, Boston, Massachusetts. 7. HIV/AIDS Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
Abstract
BACKGROUND: People living with HIV (PLWH) commonly have low bone mineral density (BMD) (low bone mass and osteoporosis) and are at high risk for fractures. Fractures and low BMD are significant causes of morbidity and mortality, increasingly relevant as PLWH age. Alcohol use is common among PLWH and known to affect bone health. The association between alcohol use and changes in BMD among PLWH is not well understood. METHODS: We conducted a 3.5-year prospective cohort study of 250 PLWH with substance use disorder or ever injection drug use. Annual alcohol consumption was measured as a mean of grams per day of alcohol, mean number of heavy drinking days per month, mean number of days abstinent per month, and any heavy drinking, using the 30-day Timeline Followback method twice each year. The primary outcome was annual change in BMD measured each year by dual energy X-ray absorptiometry in grams per square centimeter (g/cm2 ) at the femoral neck. Additional dependent variables included annual change in total hip and lumbar spine BMD, >6% annual decrease in BMD at any site, and incident fractures in the past year. Regression models adjusted for relevant covariates. RESULTS: The median age of participants was 50 years. The median duration of HIV infection was 16.5 years and the mean time since antiretroviral therapy initiation was 12.3 years. At study entry, 67% of participants met criteria for low BMD (46% low bone mass, 21% osteoporosis). Median follow-up was 24 months. We found no significant associations between any measure of alcohol consumption and changes in BMD (g/cm2 ) at the femoral neck (adjusted β for g/d of alcohol = -0.0032, p = 0.7487), total hip, or lumbar spine. There was no significant association between any measure of alcohol consumption and >6% annual decrease in BMD at any site, or incident fractures. CONCLUSIONS: In this sample of PLWH and substance use disorders or ever injection drug use, we detected no association between any of the alcohol measures used in the study and changes in BMD or incident fractures.
BACKGROUND:People living with HIV (PLWH) commonly have low bone mineral density (BMD) (low bone mass and osteoporosis) and are at high risk for fractures. Fractures and low BMD are significant causes of morbidity and mortality, increasingly relevant as PLWH age. Alcohol use is common among PLWH and known to affect bone health. The association between alcohol use and changes in BMD among PLWH is not well understood. METHODS: We conducted a 3.5-year prospective cohort study of 250 PLWH with substance use disorder or ever injection drug use. Annual alcohol consumption was measured as a mean of grams per day of alcohol, mean number of heavy drinking days per month, mean number of days abstinent per month, and any heavy drinking, using the 30-day Timeline Followback method twice each year. The primary outcome was annual change in BMD measured each year by dual energy X-ray absorptiometry in grams per square centimeter (g/cm2 ) at the femoral neck. Additional dependent variables included annual change in total hip and lumbar spine BMD, >6% annual decrease in BMD at any site, and incident fractures in the past year. Regression models adjusted for relevant covariates. RESULTS: The median age of participants was 50 years. The median duration of HIV infection was 16.5 years and the mean time since antiretroviral therapy initiation was 12.3 years. At study entry, 67% of participants met criteria for low BMD (46% low bone mass, 21% osteoporosis). Median follow-up was 24 months. We found no significant associations between any measure of alcohol consumption and changes in BMD (g/cm2 ) at the femoral neck (adjusted β for g/d of alcohol = -0.0032, p = 0.7487), total hip, or lumbar spine. There was no significant association between any measure of alcohol consumption and >6% annual decrease in BMD at any site, or incident fractures. CONCLUSIONS: In this sample of PLWH and substance use disorders or ever injection drug use, we detected no association between any of the alcohol measures used in the study and changes in BMD or incident fractures.
Authors: Upkar S Gill; Alexandra Zissimopoulos; Safa Al-Shamma; Katherine Burke; Mark J W McPhail; David A Barr; Yiannis N Kallis; Richard T C Marley; Paul Kooner; Graham R Foster; Patrick T F Kennedy Journal: J Infect Dis Date: 2014-08-25 Impact factor: 5.226
Authors: Aoife G Cotter; Caroline A Sabin; Sibongile Simelane; Alan Macken; Eoin Kavanagh; Jennifer J Brady; Geraldine McCarthy; Juliet Compston; Patrick W G Mallon Journal: AIDS Date: 2014-09-10 Impact factor: 4.177
Authors: Purificacion Rey-Sanchez; Jesus Maria Lavado-Garcia; Maria Luz Canal-Macias; Maria Trinidad Rodriguez-Dominguez; Jose Luis Bote-Mohedano; Juan Diego Pedrera-Zamorano Journal: J Bone Miner Metab Date: 2011-01-14 Impact factor: 2.626
Authors: Katherine W Kooij; Ferdinand W N M Wit; Peter H Bisschop; Judith Schouten; Ineke G Stolte; Maria Prins; Marc van der Valk; Jan M Prins; Berthe L F van Eck-Smit; Paul Lips; Peter Reiss Journal: J Infect Dis Date: 2014-09-01 Impact factor: 5.226
Authors: A Carr; B Grund; J Neuhaus; A Schwartz; J I Bernardino; D White; S Badel-Faesen; A Avihingsanon; K Ensrud; J Hoy Journal: HIV Med Date: 2015-04 Impact factor: 3.180
Authors: J L Gonzalez-Calvín; A Garcia-Sanchez; V Bellot; M Muñoz-Torres; E Raya-Alvarez; D Salvatierra-Rios Journal: Alcohol Alcohol Date: 1993-09 Impact factor: 2.826
Authors: Gerome V Escota; Kristin Mondy; Tim Bush; Lois Conley; John T Brooks; Nur Önen; Pragna Patel; Erna Milunka Kojic; Keith Henry; John Hammer; K C Wood; Kenneth A Lichtenstein; Edgar T Overton Journal: AIDS Res Hum Retroviruses Date: 2015-09-14 Impact factor: 2.205
Authors: James Watt; Jonathan Schuon; Jacob Davis; Tekeda F Ferguson; David A Welsh; Patricia E Molina; Martin J J Ronis Journal: Alcohol Clin Exp Res Date: 2019-10-01 Impact factor: 3.455
Authors: Judith A Hahn; Pamela M Murnane; Eric Vittinghoff; Winnie R Muyindike; Nneka I Emenyonu; Robin Fatch; Gabriel Chamie; Jessica E Haberer; Joel M Francis; Saidi Kapiga; Karen Jacobson; Bronwyn Myers; Marie Claude Couture; Ralph J DiClemente; Jennifer L Brown; Kaku So-Armah; Mark Sulkowski; Gregory M Marcus; Sarah Woolf-King; Robert L Cook; Veronica L Richards; Patricia Molina; Tekeda Ferguson; David Welsh; Mariann R Piano; Shane A Phillips; Scott Stewart; Majid Afshar; Kimberly Page; Kathleen McGinnis; David A Fiellin; Amy C Justice; Kendall Bryant; Richard Saitz Journal: Alcohol Clin Exp Res Date: 2021-05-07 Impact factor: 3.928
Authors: Tibor P Palfai; Jessica L Taylor; Richard Saitz; Maya P L Kratzer; John D Otis; Judith A Bernstein Journal: Addict Sci Clin Pract Date: 2019-08-29
Authors: Akila Raja; Timothy C Heeren; Alexander Y Walley; Michael R Winter; Aldina Mesic; Richard Saitz Journal: Subst Abus Date: 2020-05-06 Impact factor: 3.716
Authors: Theresa W Kim; Alicia S Ventura; Michael R Winter; Timothy C Heeren; Michael F Holick; Alexander Y Walley; Kendall J Bryant; Richard Saitz Journal: Alcohol Clin Exp Res Date: 2020-03-02 Impact factor: 3.455